跳至主要内容
临床试验/CTRI/2023/06/054440
CTRI/2023/06/054440已完成未知

A Prospective Observational Study to Assess the Efficacy & Safety of Sodium-glucose Cotransporter-2(SGLT2) Inhibitors as an Add-On drug to other Oral Hypoglycemic Agents in Reducing Glycated Hemoglobin and Weight in Type 2 Diabetes Mellitus at a Tertiary Care Hospital in Jaipur. - SWAG

Dr Mahima Makhija0 个研究点目标入组 90 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1.Patients >18 years of age.
  • 2.Patients of Type 2 DM fulfilling criteria of Type 2 DM according to American Diabetes Association (ADA) guidelines.
  • 3.Patients with Type 2 DM on other OHAs.
  • 4.T2DM Patients with other Chronic Cardiovascular issues like HTN, Heart Failure and CAD

排除标准

  • 1.Patients with eGFR <60 mL/min/1.73m2.
  • 2.Pregnant females.
  • 3.Patients not filling the criteria of Type 2 DM according to ADA guidelines.
  • 4.Patients with other contraindications to SGLT2 Inhibitors.

研究者

发起方
Dr Mahima Makhija

相似试验